Den europeiske union - dansk - EMA (European Medicines Agency)

akebia europe limited - jern citrat koordinering kompleks - hyperphosphatemia; renal dialysis - lægemidler til behandling af hyperkaliæmi og hyperphosphatæmi - fexeric er indiceret til bekæmpelse af hyperphosphatæmi hos voksne patienter med kronisk nyresygdom (ckd).

Den europeiske union - fransk - EMA (European Medicines Agency)

akebia europe limited - complexe de coordination du citrate ferrique - hyperphosphatemia; renal dialysis - médicaments pour le traitement de l'hyperkaliémie et de l'hyperphosphatémie - fexeric est indiqué pour le contrôle de l'hyperphosphatémie chez les patients adultes atteints d'insuffisance rénale chronique (irc).

Den europeiske union - svensk - EMA (European Medicines Agency)

akebia europe limited - ferrikitratkoordineringskomplex - hyperphosphatemia; renal dialysis - läkemedel för behandling av hyperkalemi och hyperfosfatemi - fexeric är indicerat för kontroll av hyperfosfatemi hos vuxna patienter med kronisk njursjukdom (ckd).

Finland - finsk - Fimea (Suomen lääkevirasto)

sanofi oy - sodium polystyrene sulfonate - jauhe oraalisuspensiota/peräruiskesuspensiota varten - polystyreenisulfonaatti

Irland - engelsk - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - calcium polystyrene sulphonate - powder for oral/rectal suspension - 99.934 percent weight/weight - drugs for treatment of hyperkalemia and hyperphosphatemia; polystyrene sulfonate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pharmacosmos a/s - calcium acetate - tablet - 1000 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; calcium acetate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

genthon b.v. - sevelamer carbonate anhydrous - film-coated tablet - 800 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; sevelamer

Irland - engelsk - HPRA (Health Products Regulatory Authority)

generics (uk) limited - sevelamer carbonate - film-coated tablet - 800 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; sevelamer - treatment of hyperkalaemia and hyperphosphataemia - sevelamer carbonate is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. sevelamer carbonate is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus
1.78 mmol/l. sevelamer carbonate should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

rowex ltd - sevelamer carbonate - film-coated tablet - 800 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; sevelamer

Den europeiske union - engelsk - EMA (European Medicines Agency)

akebia europe limited - ferric citrate coordination complex - hyperphosphatemia; renal dialysis - drugs for treatment of hyperkalaemia and hyperphosphataemia - fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (ckd).